Mild hyperhomocysteinemia has been suggested as a new, independent risk fac
tor for cardiovascular disease. This fact has produced a new, increased int
erest in the study of homocysteine metabolism and its relation to pathogene
sis. This emergent area of biomedical research is reviewed here, stressing
the biochemical and metabolic basis of the pathogenicity of increased level
s of homocysteine.